- Each capsule contains -
Efexor XR 37.5mg: Venlafaxine HCI・・・・・・・・・. 37.5mg
Efexor XR 75mg: Venlafaxine HCI・・・・・・・・・..75mg
     
   
- The world's first SNRI for first line therapy
- Excellent medical treatment rate for depression with dual action of Serotonin and Norepinephrine
- Superiority in safety and drug tolerance to TCAs
- Low potential for drug-drug interaction compared to SSRIs
- Excellent dosing flexibility
- Superior remission rate rate to SSRIs
- The only antidepressant indicated for Generalized Anxiety Disorder
- Convenient administration as a single dose per day
- Lower nausea incidence rate than Efexor IR formulation
     
   
Treatment of depression and Generalized Anxiety Disorder (GAD)
     
   
- The recommended starting dose: 75 mg/day, administered in a single dose.
- For some patients, it may be desirable to start at 37.5 mg/day for 4 to 7 days, to allow new patients to adjust to the medication before increasing to 75 mg/day.
- If after several weeks further clinical improvement is required, the dose may be increased to 150mg per day given. Patients not responding to the initial 75mg/day dose may benefit from dose increases to a maximum of approximately 225 mg/day.
- Dose increases should be in increments of up to 75 mg/day, as needed, and should be made at intervals of not less than 4 days, since steady state plasma levels of venlafaxine and its major metabolites are achieved in most patients by day 4.
     
   
100 caps.